• The Scientist
    KERX has 3 shots on goal with phase 3 studies. 1.colorectal CA 2.multiple myeloma 3.renal failure High probability at least 1 succeeds.
    11/9/11
    Reply (4)
    • TruffelPig: Two drugs, no research it seems (just development); drug seems ok though.
      11/9/11
    • The Scientist: Perifosine for multiple myeloma looks really good.Look at ASH abstract. OS 25 months! ONXX carfilzomib,applied for FDA approval, OS 15.6 mos
      11/9/11
    • The Scientist: Perifosine for multiple myeloma looks really good.Look at ASH abstract. OS 25 months! ONXX carfilzomib,applied for FDA approval, OS 15.6 mos
      11/9/11
    • TruffelPig: You are right, but I am a bit scared of companies without research in such an area. They need to buy new drug candidates.
      11/9/11